← 返回

分析效应细胞的功能异质性以增强过继性细胞疗法的应用

英文原题:Analyzing functional heterogeneity of effector cells for enhanced adoptive cell therapy applications.

查看英文原题

Analyzing functional heterogeneity of effector cells for enhanced adoptive cell therapy applications.

PubMed 2024/09/25(内容时间) Immunooncol Technol

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

细胞效应功能测定传统上依赖于掩盖复杂异质性和稀有亚群的批量细胞群体。Xdrop®液滴技术促进活单细胞或单细胞对在双乳液液滴中的高通量区室化,使得能够在单细胞水平研究单细胞或细胞间相互作用。效应细胞分子分泌和靶细胞杀伤可以独立或联合评估。与多种商业测定试剂的兼容性允许使用流式细胞术或显微镜等常见实验室技术进行单细胞水平读数。此外,感兴趣的单个细胞可以被活体分离以用于进一步研究或扩增。在此,我们展示了双乳液液滴技术在常用于癌症过继细胞治疗的一系列细胞类型中的应用:NK 细胞、血液来源T细胞、TIL(肿瘤浸润淋巴细胞)和CAR-T 细胞。单细胞区室化提供了无与伦比的分辨率,是推进细胞治疗产品开发和理解的有价值工具。

展开英文摘要原文

Cellular effector function assays traditionally rely on bulk cell populations that mask complex heterogeneity and rare subpopulations. The Xdrop® droplet technology facilitates high-throughput compartmentalization of viable single cells or single-cell pairs in double-emulsion droplets, enabling the study of single cells or cell-cell interactions at an individual level.

Effector cell molecule secretion and target cell killing can be evaluated independently or in combination. Compatibility with a wide range of commercial assay reagents allows for single-cell level readouts using common laboratory techniques such as flow cytometry or microscopy.

Moreover, individual cells of interest can be viably isolated for further investigation or expansion.

Here we demonstrate the application of the double-emulsion droplet technology with a range of cell types commonly utilized for adoptive cell therapy of cancer: natural killer cells, blood-derived T cells, tumor-infiltrating lymphocytes, and chimeric antigen receptor T cells. Single-cell compartmentalization offers unparalleled resolution, serving as a valuable tool for advancing the development and understanding of cellular therapy products.

论文信息

作者
Kiel Rasmussen AC、Hulen TM、Petersen DL、Jacobsen MJ、Mikkelsen MJ、Met Ö、Donia M、Chamberlain CA
第一作者单位
Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.Denmark
通讯作者单位
Samplix ApS, Birkerød, Denmark.Denmark
文献类型
综述
期刊
Immuno-oncology technology2024 Dec
原文标识
PubMed 39629159 · DOI 10.1016/j.iotech.2024.100738